title: Discussion: using benzodiazepines in clinical practice.
authors.forename: Samantha A
authors.initials: SA
authors.lastname: Stewart
authors.forename: Jerold F
authors.initials: JF
authors.lastname: Rosenbaum
authors.forename: Mark H
authors.initials: MH
authors.lastname: Pollack
authors.forename: Peter P
authors.initials: PP
authors.lastname: Roy-Byrne
authors.forename: Charles P
authors.initials: CP
authors.lastname: O'Brien
authors.forename: Michael W
authors.initials: MW
authors.lastname: Otto
mesh_terms: D000437:Alcoholism / Q000150:complications / Q000523:psychology; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology / Q000628:therapy; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000139:chemically induced; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D006801:Humans
chemical_list: D014151:Anti-Anxiety Agents; D001569:Benzodiazepines